811 related articles for article (PubMed ID: 20522742)
1. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.
Hidvegi T; Ewing M; Hale P; Dippold C; Beckett C; Kemp C; Maurice N; Mukherjee A; Goldbach C; Watkins S; Michalopoulos G; Perlmutter DH
Science; 2010 Jul; 329(5988):229-32. PubMed ID: 20522742
[TBL] [Abstract][Full Text] [Related]
2. Medicine. Clearing conformational disease.
Sifers RN
Science; 2010 Jul; 329(5988):154-5. PubMed ID: 20616258
[No Abstract] [Full Text] [Related]
3. Alpha1-antitrypsin deficiency and autophagy.
Marciniak SJ; Lomas DA
N Engl J Med; 2010 Nov; 363(19):1863-4. PubMed ID: 21047232
[No Abstract] [Full Text] [Related]
4. Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiency.
Wang Y; Perlmutter DH
Pediatr Res; 2014 Jan; 75(1-2):133-9. PubMed ID: 24226634
[TBL] [Abstract][Full Text] [Related]
5. Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency.
Li J; Pak SC; O'Reilly LP; Benson JA; Wang Y; Hidvegi T; Hale P; Dippold C; Ewing M; Silverman GA; Perlmutter DH
PLoS One; 2014; 9(1):e87260. PubMed ID: 24498058
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1-antitrypsin deficiency: importance of proteasomal and autophagic degradative pathways in disposal of liver disease-associated protein aggregates.
Perlmutter DH
Annu Rev Med; 2011; 62():333-45. PubMed ID: 20707674
[TBL] [Abstract][Full Text] [Related]
7. Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin Deficiency.
Li J; Moretti F; Hidvegi T; Sviben S; Fitzpatrick JAJ; Sundaramoorthi H; Pak SC; Silverman GA; Knapp B; Filipuzzi I; Alford J; Reece-Hoyes J; Nigsch F; Murphy LO; Nyfeler B; Perlmutter DH
Cell Mol Gastroenterol Hepatol; 2024; 17(6):1007-1024. PubMed ID: 38336172
[TBL] [Abstract][Full Text] [Related]
8. The role of autophagy in alpha-1-antitrypsin deficiency.
Hidvegi T; Mukherjee A; Ewing M; Kemp C; Perlmutter DH
Methods Enzymol; 2011; 499():33-54. PubMed ID: 21683248
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency.
Pastore N; Blomenkamp K; Annunziata F; Piccolo P; Mithbaokar P; Maria Sepe R; Vetrini F; Palmer D; Ng P; Polishchuk E; Iacobacci S; Polishchuk R; Teckman J; Ballabio A; Brunetti-Pierri N
EMBO Mol Med; 2013 Mar; 5(3):397-412. PubMed ID: 23381957
[TBL] [Abstract][Full Text] [Related]
10. The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins.
Perlmutter DH
Autophagy; 2006; 2(4):258-63. PubMed ID: 16874089
[TBL] [Abstract][Full Text] [Related]
11. An analog of glibenclamide selectively enhances autophagic degradation of misfolded α1-antitrypsin Z.
Wang Y; Cobanoglu MC; Li J; Hidvegi T; Hale P; Ewing M; Chu AS; Gong Z; Muzumdar R; Pak SC; Silverman GA; Bahar I; Perlmutter DH
PLoS One; 2019; 14(1):e0209748. PubMed ID: 30673724
[TBL] [Abstract][Full Text] [Related]
12. Regulation of PGC1α Downstream of the Insulin Signaling Pathway Plays a Role in the Hepatic Proteotoxicity of Mutant α1-Antitrypsin Deficiency Variant Z.
Rudnick DA; Huang J; Hidvegi T; Chu AS; Hale P; Munanairi A; Dietzen DJ; Cliften PF; Tycksen E; Lutkewitte AJ; Finck BN; Pak SC; Silverman GA; Perlmutter DH
Gastroenterology; 2022 Jul; 163(1):270-284. PubMed ID: 35301011
[TBL] [Abstract][Full Text] [Related]
13. Alpha1-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum.
Perlmutter DH
Methods Mol Biol; 2003; 232():39-56. PubMed ID: 12840538
[No Abstract] [Full Text] [Related]
14. Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders.
Perlmutter DH; Silverman GA
Cold Spring Harb Perspect Biol; 2011 Mar; 3(3):. PubMed ID: 21421920
[TBL] [Abstract][Full Text] [Related]
15. NFκB mitigates the pathological effects of misfolded α1-antitrypsin by activating autophagy and an integrated program of proteostasis mechanisms.
Mukherjee A; Hidvegi T; Araya P; Ewing M; Stolz DB; Perlmutter DH
Cell Death Differ; 2019 Mar; 26(3):455-469. PubMed ID: 29795336
[TBL] [Abstract][Full Text] [Related]
16. Bile Duct Ligation Induces ATZ Globule Clearance in a Mouse Model of α-1 Antitrypsin Deficiency.
Khan Z; Yokota S; Ono Y; Bell AW; Oertel M; Stolz DB; Michalopoulos GK
Gene Expr; 2017 Feb; 17(2):115-127. PubMed ID: 27938510
[TBL] [Abstract][Full Text] [Related]
17. FBG1 Is the Final Arbitrator of A1AT-Z Degradation.
Wen JH; Wen H; Gibson-Corley KN; Glenn KA
PLoS One; 2015; 10(8):e0135591. PubMed ID: 26295339
[TBL] [Abstract][Full Text] [Related]
18. Regulator of G Signaling 16 is a marker for the distinct endoplasmic reticulum stress state associated with aggregated mutant alpha1-antitrypsin Z in the classical form of alpha1-antitrypsin deficiency.
Hidvegi T; Mirnics K; Hale P; Ewing M; Beckett C; Perlmutter DH
J Biol Chem; 2007 Sep; 282(38):27769-80. PubMed ID: 17635928
[TBL] [Abstract][Full Text] [Related]
19. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
[TBL] [Abstract][Full Text] [Related]
20. A C. elegans model of human α1-antitrypsin deficiency links components of the RNAi pathway to misfolded protein turnover.
Long OS; Benson JA; Kwak JH; Luke CJ; Gosai SJ; O'Reilly LP; Wang Y; Li J; Vetica AC; Miedel MT; Stolz DB; Watkins SC; Züchner S; Perlmutter DH; Silverman GA; Pak SC
Hum Mol Genet; 2014 Oct; 23(19):5109-22. PubMed ID: 24838286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
